Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF
Open Access
- 8 July 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 56 (3), 594-597
- https://doi.org/10.1093/jac/dki252
Abstract
Objectives: In view of the poor therapy outcomes of invasive aspergillosis, the objective of this study was to evaluate the efficacy of combination treatment consisting of the polyene amphotericin-B-intralipid, the echinocandin caspofungin and granulocyte-colony stimulating factor (G-CSF) in experimental murine systemic aspergillosis. With inhibition of synthesis of 1,3-β-d-glucan in the fungal cell wall by caspofungin and an effect on the cell membrane by amphotericin-B-intralipid, this treatment may result in a synergic effect against Aspergillus fumigatus. Addition of G-CSF may further contribute to therapy of aspergillosis. Methods: ICR mice were immunosuppressed by intraperitoneal administration of cyclophosphamide. Three days later, the mice were inoculated intravenously (iv) with A. fumigatus conidia. Infection and treatment were evaluated during an observation period of 30 days in terms of mortality (survival rate and mean survival time) and morbidity (quantitative determination of fungal burden, histopathology, and detection of serum galactomannan). Results: Combination of caspofungin + G-CSF or addition of G-CSF to the combination of caspofungin + amphotericin-B-intralipid increased the survival rate of infected mice up to 78.9% and prolonged their mean survival time to 25 days. These combinations also resulted in a reduction in fungal burden in organs, and a decrease in serum galactomannan. Conclusions: The successful results obtained in the experimental model may possibly open the way to more effective management of aspergillosis in humans.Keywords
This publication has 10 references indexed in Scilit:
- Treatment of murine systemic aspergillosis with polyene-intralipid admixturesMedical Mycology, 2004
- Polyene and cytokine treatment of experimental aspergillosisFEMS Immunology & Medical Microbiology, 2003
- Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so farDrug Resistance Updates, 2003
- Invasive Aspergillosis in 2002: An UpdateEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infectionsExpert Opinion on Investigational Drugs, 2001
- Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic miceAntimicrobial Agents and Chemotherapy, 1997
- The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures [published erratum appears in J Antimicrob Chemother 1998 Sep;42(3):413]Journal of Antimicrobial Chemotherapy, 1997
- Therapeutic Outcome in Invasive AspergillosisClinical Infectious Diseases, 1996
- Immunomodulators and Fungal Infections: Use of Antifungal Drugs in Combination with G-CSFAdvances in experimental medicine and biology, 1992
- Granulocyte Colony-Stimulating Factor Enhances the Phagocytic and Bactericidal Activity of Normal and Defective Human NeutrophilsThe Journal of Infectious Diseases, 1991